Read More Analyst Ratings News Price Target Needham Maintains Buy on Vicor, Lowers Price Target to $75 By Benzinga Newsdesk Today, 11:43 PM Needham analyst Quinn Bolton maintains Vicor (NASDAQ:VICR) with a Buy and lowers the price target from $90 to $75. VICR
Read More Analyst Ratings News Upgrades B of A Securities Upgrades Helmerich & Payne to Neutral By Benzinga Newsdesk Today, 11:43 PM B of A Securities analyst Chase Mulvehill upgrades Helmerich & Payne (NYSE:HP) from Underperform to Neutral. HP
Read More Analyst Ratings News Price Target Truist Securities Maintains Hold on Airbnb, Raises Price Target to $190 By Benzinga Newsdesk Today, 11:43 PM Truist Securities analyst Naved Khan maintains Airbnb (NASDAQ:ABNB) with a Hold and raises the price target from $180 to $190. ABNB
Read More Cannabis Government M&A Markets News Regulations Tilray CEO: Expand The Company’s Medical Cannabis Business, ‘Opportunities Are Tremendous’ By Nicolas Jose Rodriguez Today, 11:43 PM Irwin Simon, CEO of Canada-based cannabis company Tilray (NASDAQ: TLRY), said Thursday on CNBC that the company intends to drive growth by building its medica TLRY